<DOC>
	<DOCNO>NCT01399203</DOCNO>
	<brief_summary>To investigate predictive value contrast medium volume creatinine clearance ( V/CrCl ) ratio risk contrast-induced nephropathy ( CIN ) ( i.e. , within 48-72 h ) determine relatively safe V/CrCl cut-off value avoid CIN patient follow PCI</brief_summary>
	<brief_title>Contrast Medium Volume Contrast-induced Nephropathy After Percutaneous Coronary Intervention</brief_title>
	<detailed_description>contrast medium volume creatinine clearance ( V/CrCl ) ratio obtain consecutive consenting patient unselective PCI . Receiver-operator characteristic ( ROC ) curve use identify optimal sensitivity observe range V/CrCl . The predictive value V/CrCl risk CIN assess use multivariate logistic regression .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<criteria>patient agree stay hospital 23 day percutaneous coronary intervention provide write informed consent Creatinine Clearance:1560ml/min pregnancy lactation intravascular administration contrast medium within previous seven day treatment metformin aminoglycosides Nacetylcysteine ( NAC ) nonsteroidal antiinflammatory drug within previous 48 h intake nephrotoxic drug within previous seven day history serious reaction contrast medium severe concomitant disease renal transplantation , endstage renal disease necessitate dialysis patient die percutaneous coronary intervention</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>contrast-induced nephropathy</keyword>
	<keyword>contrast medium</keyword>
	<keyword>creatinine clearance</keyword>
	<keyword>percutaneous coronary intervention</keyword>
</DOC>